SPOPL通过激活Notch信号通路诱导胶质瘤干细胞致瘤性与干性
研究探讨SPOPL在胶质瘤干细胞(GSCs)中的表达及对胶质母细胞瘤(GBM)预后的影响,利用临床标本、患者来源原代GSCs和公共数据库,并在体内外验证其功能。结果显示SPOPL在GSCs和GBM中显著上调,高表达者预后更差,SPOPL增强GSCs增殖、自我更新和致瘤性,Notch信号通路在SPOPL敲低GSCs中显著受抑,激活或抑制Notch通路可逆转SPOPL表达改变引起的生物学功能变化。
要点
- SPOPL在胶质瘤干细胞和胶质母细胞瘤中表达显著上调,高表达患者预后更差。
- SPOPL增强胶质瘤干细胞的增殖、自我更新能力和致瘤性。
- SPOPL通过激活Notch信号通路促进胶质瘤干细胞增殖与干性。
核心结论
- SPOPL可作为GBM临床工作中的潜在预后生物标志物,并通过激活Notch信号通路促进GSCs增殖和干性,可能是靶向GSCs治疗GBM的潜在分子。
研究设计与样本
- 利用临床标本、患者来源原代GSCs和公共数据库研究SPOPL在GSCs中的表达及其对GBM患者预后的影响。
- 在体内和体外探究SPOPL对GSCs增殖、自我更新和分化能力的影响。
- 使用RNA测序(RNA-seq)和 rescue 实验探究SPOPL影响GSCs生物学功能的机制。
主要发现
- SPOPL在GSCs和GBM中表达显著上调,高表达SPOPL患者预后更差。
- SPOPL增强GSCs的增殖和自我更新能力,并增强GSCs的致瘤性。
- Notch信号通路在SPOPL敲低GSCs中显著受抑制。
- 激活或抑制Notch信号通路可逆转SPOPL表达改变引起的GSCs生物学功能变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent studies have increasingly shown that glioma stem cells (GSCs) are extremely important for developing and treating glioblastoma multiforme (GBM). The Broad-complex, Tram-track, and Bric-a-brac protein family is functionally related to a variety of tumor stem cells, and the role of SPOPL as a member of this family in GSCs deserves to be investigated. METHODS: To investigate the expression of SPOPL in GSCs and its impact on the prognosis of GBM patients by using clinical specimens, patient-derived primary GSCs and public databases. In vivo and in vitro, the effect of SPOPL on the proliferation, self-renewal, and differentiation ability of GSCs was explored. Probing the mechanism by which SPOPL affects the biological function of GSCs using RNA sequencing (RNA-seq) and rescue experiments. RESULTS: The expression of SPOPL was significantly upregulated in GSCs and GBM, and patients with high SPOPL expression had a poorer prognosis. SPOPL enhanced the proliferation and self-renewal ability of GSCs and enhanced the tumorigenicity of GSCs. The Notch signaling pathway was significantly inhibited in SPOPL knockdown GSCs. Activation or inhibition of the Notch signaling pathway rescued changes in the biological function of GSCs caused by altered SPOPL expression. CONCLUSION: SPOPL can be used as a potential prognostic biomarker for GBM in clinical work and promotes the proliferation and stemness of GSCs by activating the Notch signaling pathway, which may be a potential molecule for targeting GSCs to treat GBM.
引用
- Hu T, Xuan R, Han E, et al. SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling. J Neurooncol. 2023. PMID: 37523046. doi:10.1007/s11060-023-04394-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。